Over the course of the past trading week, the ViaDerma Inc (OTCMKTS:VDRM) stock emerged as one of the major gainers and ended up soaring by as much as threefold.
The rally in the ViaDerma was triggered earlier on in the week when the company announced that it was in the final stage of talks with a prominent healthcare network with regards to an initial order for its wound care product Vitastem. It is a significant development for the company and the rally in the stock is understandable.
The product had been tested by the healthcare network towards the end of 2020 and eventually, approval was given for the initial order. After the initial order is completed by ViaDerma, the product is going to be made available in hospices, hospitals, and nursing homes. Considering the magnitude of the gains made by the stock, it might be a good idea for investors to keep an eye on the ViaDerma stock this week.